Kazuki Maesaka

585 total citations
12 papers, 210 citations indexed

About

Kazuki Maesaka is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Kazuki Maesaka has authored 12 papers receiving a total of 210 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hepatology, 4 papers in Epidemiology and 3 papers in Oncology. Recurrent topics in Kazuki Maesaka's work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Liver Disease Diagnosis and Treatment (4 papers) and Hepatitis C virus research (3 papers). Kazuki Maesaka is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Liver Disease Diagnosis and Treatment (4 papers) and Hepatitis C virus research (3 papers). Kazuki Maesaka collaborates with scholars based in Japan. Kazuki Maesaka's co-authors include Ryotaro Sakamori, Hayato Hikita, Tomohide Tatsumi, Takahiro Kodama, Tetsuo Takehara, Kazuyoshi Ohkawa, Eiji Mita, Ryoko Yamada, Yuki Tahata and Takayuki Yakushijin and has published in prestigious journals such as Clinical Cancer Research, Energy and Medicine.

In The Last Decade

Kazuki Maesaka

12 papers receiving 209 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kazuki Maesaka Japan	7	138	84	45	43	43	12	210
Derek-Zhen Xu China	5	124 0.9×	91 1.1×	47 1.0×	31 0.7×	24 0.6×	6	171
Songqiang Zhou China	9	178 1.3×	107 1.3×	56 1.2×	69 1.6×	49 1.1×	15	294
Xuqi Sun China	8	192 1.4×	115 1.4×	47 1.0×	76 1.8×	71 1.7×	27	282
Alexander Vasilyev Russia	2	196 1.4×	158 1.9×	61 1.4×	66 1.5×	32 0.7×	3	284
Roger Esteban-Fabró Spain	4	70 0.5×	61 0.7×	23 0.5×	29 0.7×	71 1.7×	8	152
Linfeng Xu China	10	128 0.9×	40 0.5×	39 0.9×	63 1.5×	64 1.5×	24	251
Takashi Mineo Japan	4	70 0.5×	85 1.0×	21 0.5×	24 0.6×	30 0.7×	12	168
Cheng‐Qian Zhong China	9	139 1.0×	47 0.6×	29 0.6×	71 1.7×	77 1.8×	20	277
Satheesh Chiradoni Thungappa India	4	201 1.5×	174 2.1×	65 1.4×	67 1.6×	32 0.7×	13	305
Kenichiro Kodama Japan	8	135 1.0×	61 0.7×	45 1.0×	55 1.3×	47 1.1×	13	194

Countries citing papers authored by Kazuki Maesaka

Since Specialization

Citations

This map shows the geographic impact of Kazuki Maesaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuki Maesaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuki Maesaka more than expected).

Fields of papers citing papers by Kazuki Maesaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuki Maesaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuki Maesaka. The network helps show where Kazuki Maesaka may publish in the future.

Co-authorship network of co-authors of Kazuki Maesaka

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuki Maesaka. A scholar is included among the top collaborators of Kazuki Maesaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuki Maesaka. Kazuki Maesaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Muromachi, Sanehiro, et al.. (2023). Biogas separation by semiclathrate hydrates formed with tetra-n-butylammonium and tetra-n-butylphosphonium salts. Energy. 290. 130176–130176. 6 indexed citations

Maesaka, Kazuki, Ryotaro Sakamori, Ryoko Yamada, et al.. (2022). Comparison of atezolizumab plus bevacizumab and lenvatinib in terms of efficacy and safety as primary systemic chemotherapy for hepatocellular carcinoma. Hepatology Research. 52(7). 630–640. 31 indexed citations

Myojin, Yuta, Takahiro Kodama, Ryotaro Sakamori, et al.. (2022). Interleukin-6 Is a Circulating Prognostic Biomarker for Hepatocellular Carcinoma Patients Treated with Combined Immunotherapy. Cancers. 14(4). 883–883. 57 indexed citations

Maesaka, Kazuki, Ryotaro Sakamori, Ryoko Yamada, et al.. (2021). Hyperprogressive disease in patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapy. Hepatology Research. 52(3). 298–307. 27 indexed citations

Maesaka, Kazuki, Ryotaro Sakamori, Ryoko Yamada, et al.. (2021). Clinical course of hepatitis C virus‐positive patients with decompensated liver cirrhosis in the era of direct‐acting antiviral treatment. Hepatology Research. 51(5). 517–527. 3 indexed citations

Maesaka, Kazuki, Ryotaro Sakamori, Ryoko Yamada, et al.. (2021). Efficacy of Ramucirumab Versus Sorafenib as Subsequent Treatment for Hepatocellular Carcinoma. Anticancer Research. 41(4). 2187–2192. 3 indexed citations

Myojin, Yuta, Takahiro Kodama, Kazuki Maesaka, et al.. (2020). ST6GAL1 Is a Novel Serum Biomarker for Lenvatinib-Susceptible FGF19-Driven Hepatocellular Carcinoma. Clinical Cancer Research. 27(4). 1150–1161. 57 indexed citations

Maesaka, Kazuki, Ryotaro Sakamori, Ryoko Yamada, et al.. (2020). Initial treatment response to transarterial chemoembolization as a predictive factor for Child–Pugh class deterioration prior to refractoriness in hepatocellular carcinoma. Hepatology Research. 50(11). 1275–1283. 4 indexed citations

Maesaka, Kazuki, Ryotaro Sakamori, Ryoko Yamada, et al.. (2020). Therapeutic efficacy of lenvatinib in hepatocellular carcinoma patients with portal hypertension. Hepatology Research. 50(9). 1091–1100. 2 indexed citations

10.

Sakamori, Ryotaro, Kazuki Maesaka, Ryoko Yamada, et al.. (2020). Lower Serum Sodium Levels Are Associated with the Therapeutic Effect of Sorafenib on Hepatocellular Carcinoma. Digestive Diseases and Sciences. 66(5). 1720–1729. 6 indexed citations

11.

Maesaka, Kazuki, Ryotaro Sakamori, Ryoko Yamada, et al.. (2019). Hypovascular hepatic nodules as a predictive factor for transcatheter arterial chemoembolization refractoriness in hepatocellular carcinoma. Hepatology Research. 50(3). 365–373. 12 indexed citations

12.

Maesaka, Kazuki, Yoshiki Tsujii, Shinichiro Shinzaki, et al.. (2018). Successful treatment of drug-induced esophageal ulcer in a patient with chronic heart failure. Medicine. 97(48). e13380–e13380. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact